Fig. 2From: Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumoniaMedian 30, 60, and 90-day mortality in HCAP patients treated with vancomycin or linezolid, HCAP healthcare-associated pneumonia, OR odds ratio, CI confidence interval. The figure depicts crude mortality rates. The adjusted odds ratios and 95 % confidence intervals were derived from multivariable logistic regression models; see text for covariatesBack to article page